Natco Pharma EBITDA per Share

What does Natco Pharma do? Natco Pharma Ltd is an Indian pharmaceutical company that was founded in 1981. It is headquartered in Hyderabad, India and also operates branches in other parts of India and overseas. History Natco Pharma Ltd was founded by Dr. Devinder Pal Singh. The company started as a small generic drug manufacturing company but gradually expanded and today is one of the leading pharmaceutical companies in India. In the early 2000s, Natco Pharma Ltd entered the international market and has since conducted many important partnerships and acquisitions to expand its business. Business model Natco Pharma Ltd's business model focuses on the research, development, and manufacturing of drugs used in various therapeutic areas. The company primarily produces generics but also biosimilars and innovative products. Natco Pharma Ltd aims to provide affordable and accessible medications to patients in India and worldwide. Products and divisions Natco Pharma Ltd produces a wide range of medications divided into various divisions. The company's main divisions include oncology, hepatitis C, nephrology, neurology, cardiology, and anti-infectives. Natco Pharma Ltd also offers a range of biosimilars, including pegfilgrastim and trastuzumab, and has launched innovative products such as Natdac (daclatasvir) and Hepcinat LP (sofosbuvir and ledipasvir). The company also has a separate department for the production of active pharmaceutical ingredients (APIs) and has multiple manufacturing facilities in different parts of India certified by strict international quality standards (such as USFDA, UK-MHRA, and TGA). Activities Natco Pharma Ltd has been involved in several patent litigation cases to facilitate access to affordable generic medications. A significant example is the patented cancer drug Nexavar by Bayer. Natco Pharma Ltd won a long legal battle, allowing it to bring a cheaper version of the drug to the market. Natco Pharma Ltd has also built partnerships with other pharmaceutical companies to promote the distribution of its medications on a global level. One important collaboration of the company is with Mylan to manufacture affordable versions of HIV/AIDS medications for developing countries. Conclusion Natco Pharma Ltd is a strong example of a company that has been able to grow through quality, research, and affordable products. It has also been involved in several patent disputes to improve access to affordable medications. The wide range of medications and divisions shows that Natco Pharma Ltd is a significant player in the Indian and international market. Natco Pharma is one of the most popular companies on Eulerpool.